Clinical trial Recruiting at 1 site Interventional Ages 18 and up

Symani Restore surgery for Moyamoya disease

Official title: An Early Feasibility Study for the Symani Surgical System

Run by Jacobs institute · NCT07140731 · Data updated 2026-11-12

This study tests using the Symani Surgical System to assist surgeons performing neurosurgery in adults with moyamoya disease.

Quick facts

Study typeInterventional
Ages18 Years and up
SexAll
Enrollment15 (estimated)
SponsorJacobs institute
Academic / other
Locations1 site (Buffalo, New York)
StatusRecruiting
StartedSeptember 20, 2025
Main results expectedSeptember 1, 2027
Study endsSeptember 1, 2027
Registry record updatedOctober 16, 2025
Trial IDNCT07140731 on ClinicalTrials.gov

Is this trial a fit for you?

Likely a good fit

Adults over 18 with moyamoya disease who have minor to moderate symptoms and are candidates for neurosurgical treatment and general anesthesia are ideal candidates.

Probably not a fit

Patients with current or past bleeding/coagulation disorders, those who cannot tolerate prolonged anesthesia, hemodynamically unstable neurological exams, or pressure-dependent neurologic status are unlikely to benefit from this study.

A plain-English reading of the study's rules. Only the study team can confirm whether you qualify.

What this trial studies

This is a prospective, interventional study of the Symani Surgical System in adults with moyamoya disease who require neurosurgical treatment. Eligible patients (>18 years) will undergo the planned surgical procedure with the aid of the Symani device and will be followed for safety and device-related outcomes. The trial enrolls patients at the Jacobs Institute in Buffalo, New York, and applies standard inclusion and exclusion criteria for operative candidates. Investigators will record perioperative safety, technical performance, and clinical recovery measures to determine device effectiveness in this population.

Why it matters

Potential benefit: If successful, using the Symani system could improve the precision of delicate cerebrovascular procedures and potentially reduce surgical complications.

How similar studies have gone: Robotic-assisted microsurgery has shown promise in other microvascular procedures, but application specifically for moyamoya disease is limited and this study is among the early tests of Symani in this setting.

Who can join: the full rules

Show full inclusion / exclusion criteria
Inclusion Criteria:

1. Patients aged \>18.
2. Moyamoya disease with minor to moderate symptoms requiring neurosurgical treatment.
3. Patients agree to have the surgery and the anesthesia.
4. Patients who voluntarily decide to participate in this study with the surgery performed with the aid of Symani and agree to sign the Informed Consent Form.

   \-

Exclusion Criteria:

1. Patients who have bleeding or coagulation disorders in the past or present.
2. Any criteria that preclude prolonged anesthesia.
3. Hemodynamically unstable neurological exam.
4. Pressure dependent neurologic status.

Where it's running

  • Jacobs Institute
    Buffalo, New York, United States
    Recruiting

Study contacts

Similar studies

Other studies for the same condition or treatment. Recruiting studies are listed first.

How to take part

  1. Review the eligibility criteria above with your treating physician.
  2. Check the official listing on ClinicalTrials.gov for the latest contact details and recruitment status.
  3. Contact the study coordinator or principal investigator to ask for pre-screening. Pre-screening is free and never obligates you to enroll.
Last reviewed 2026-11-14 by the Find a Trial editorial team. Information on this page is for educational purposes and is not medical advice. Always consult qualified healthcare professionals about clinical trial participation.